Covariate | All patients receiving basal insulin (N=113) Mean (SD) | All patients receiving OAD (N=408) Mean (SD) | p Value |
---|---|---|---|
HbA1c (%) | |||
Abs change from baseline | −1.8 (2.4) | −1.2 (2.0) | 0.17 |
Rel change from baseline | −0.2 (0.2) | −0.1 (0.2) | 0.19 |
FPG (mmol/L) | |||
Abs change from baseline | −1.2 (4.2) | −0.7 (5.2) | 0.97 |
Rel change from baseline | −0.1 (0.5) | 0.0 (0.7) | 0.88 |
PPG (mmol/L) | |||
Abs change from baseline | −2.8 (6.4) | −2.2 (13.6) | 0.81 |
Rel change from baseline | −0.1 (0.5) | −0.1 (1.0) | 0.97 |
Body weight (kg) | |||
Abs change from baseline | 0.98 (7.1) | −1.52 (11.8) | <0.001 |
Rel change from baseline | 0.014 (0.08) | −0.015 (0.12) | <0.001 |
p Values provided by multivariate linear regression accounting for all continuous baseline covariates and gender. Bold formats indicate significance.
Abs, absolute; FPG, fasting plasma glucose; HbA1c, glycated hemoglobin; NA, not applicable; OAD, antidiabetic oral drug; PPG, postprandial glucose; Rel, relative.